Hong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study

According to the results of a randomized, double-blind, placebo-controlled clinical trial published in the Lancet, researchers in Hong Kong investigated treatment with SMI01, a synbiotic preparation of three lyophilised Bifidobacteria…

Continue ReadingHong Kong Researchers Examine Synbiotic Preparation for Post-COVID-19 Syndrome in Randomized, Double Blind, Placebo-Controlled Study